Crossmark

Associations between serum glucose, insulin, insulin resistance and the risk of incident primary liver cancer or chronic liver disease mortality: a nested case–control study

Crossref DOI link: https://doi.org/10.1038/s41416-022-02042-8

Published Online: 2022-12-10

Published Print: 2023-01-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yin, Jian https://orcid.org/0000-0002-4874-3810
Freedman, Neal D.

Liu, Yiwei

Dawsey, Sanford M.

Yang, Huan

Taylor, Philip R.

Yin, Liangyu

Liu, Bin

Cui, Jianfeng

Fan, Jinhu

Chen, Wen https://orcid.org/0000-0002-6603-0056
Qiao, Youlin https://orcid.org/0000-0001-6380-0871
Abnet, Christian C.
Funding

Funding for this research was provided by:

Division of Cancer Prevention, National Cancer Institute (N01-SC-91030, N01-RC-47701, N02CP-2017-00047)
License Information

Text and Data Mining valid from 2022-12-10

Version of Record valid from 2022-12-10
More Information

Article History

Received: 11 April 2022

Revised: 31 August 2022

Accepted: 19 October 2022

First Online: 10 December 2022

Competing interests

: The authors declare no competing interests.

: The study was performed according to the guidelines of the Helsinki declaration. All consent procedures, including human specimen collection, were approved by the Institutional Review Boards of the U.S. National Institutes of Health and the Chinese Academy of Medical Sciences (Beijing, China), and all participants provided written informed consent.

: Not applicable.

Document is current

Any future updates will be listed below